Silence Therapeutics Income Statement (2019-2025) | SLN

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.00B0.01B0.00B0.00B4,350.81B0.00B0.01B0.00B0.00B0.01B0.01B0.01B0.00B0.00B0.02B0.00B0.00B0.03B0.00B0.00B0.00B
Cost of Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Gross Profit -442.640.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.00B0.00B0.01B-0.00B-0.00B0.02B0.00B0.00B0.00B
Operating items
Research & Development -0.02B-4.48B-0.03B-10.28B-0.01B-0.01B0.07B-0.01B-0.01B-0.01B0.07B-0.02B-0.02B-0.01B0.10B0.01B0.01B0.02B0.02B0.02B0.02B0.02B
Selling, General & Administrative -0.01B-3.44B-0.02B-5.17B-0.01B-0.01B0.05B-0.01B-0.01B-0.01B0.04B-0.01B-0.01B-0.01B0.05B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Restructuring Costs 0.00B
Other Operating Expenses -0.03B-0.02B
Operating Expenses -0.03B-7.92B-0.05B-15.45B-0.02B-0.02B0.12B-0.02B-0.02B-0.02B0.12B-0.02B-0.02B-0.02B0.14B-0.00B-0.00B-0.03B0.03B0.00B0.00B0.03B
Operating Income -0.03B-0.00B-0.05B-0.00B-0.02B-0.02B-0.02B-0.01B-0.02B-0.02B-0.01B-0.01B-0.01B-0.02B-0.02B-0.01B-0.02B-0.03B-0.00B-0.03B-0.02B-0.03B
EBIT -0.03B-0.00B-0.05B-0.00B-0.02B-0.02B-0.02B-0.01B-0.02B-0.02B-0.01B-0.01B-0.01B-0.02B-0.02B-0.01B-0.02B-0.03B-0.00B-0.03B-0.02B-0.03B
Non-operating items
Non Operating Investment Income -0.00B
Interest & Investment Income 0.19B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.01B-0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B
Other Non Operating Income -3.99B-0.00B0.36B-0.00B-0.36B-0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.01B0.02B-0.00B-0.01B0.00B
Net income details
EBT -0.03B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B
Tax Provisions 0.00B0.00B0.00B0.00B0.00B0.00B
Profit After Tax -0.03B-0.01B-0.04B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B
Income from Continuing Operations -0.03B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B
Consolidated Net Income -0.03B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B
Income towards Parent Company -0.03B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B
Net Income towards Common Stockholders -0.03B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.01B-0.02B-0.02B-0.02B-0.01B-0.02B-0.00B-0.02B-0.04B0.01B-0.03B-0.03B-0.02B
Additional items
EPS (Basic) -0.16-0.17-0.02-0.14-0.250.09-0.20-0.19-0.15
EPS (Weighted Average and Diluted) -0.16-0.17-0.02-0.14-0.250.09-0.20-0.19-0.15
Shares Outstanding (Weighted Average) 0.11B0.14B0.17B0.18B0.18B0.14B0.14B0.14B0.14B
Shares Outstanding (Diluted Average) 0.11B0.14B0.17B0.18B0.18B0.14B0.14B0.14B0.14B
EBITDA -0.03B-0.00B-0.05B-0.00B-0.02B-0.02B-0.02B-0.01B-0.02B-0.02B-0.01B-0.01B-0.01B-0.02B-0.02B-0.01B-0.02B-0.03B-0.00B-0.03B-0.02B-0.03B
Tax Rate -11.80%-1.17%-0.14%2.57%-0.04%0.00%